The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...
GlobalData on MSN5d
Valneva’s chikungunya vaccine wins UK approvalValneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...
This development comes a week after Bavarian Nordic’s vaccine Vimkunya moved closer to the European market, having received an EMA recommendation for marketing authorisation on 31 January.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback